These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25563142)

  • 1. Screening for liver cancer during transplant waiting list: a multicenter study from South America.
    Piñero F; Marciano S; Anders M; Orozco F; Zerega A; Cabrera CR; Baña MT; Gil O; Andriani O; de Santibañes E; McCormack L; Gadano A; Silva M
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):355-60. PubMed ID: 25563142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
    Piñero F; Costa P; Boteon YL; Duque SH; Marciano S; Anders M; Varón A; Zerega A; Poniachik J; Soza A; Machaca MP; Menéndez J; Zapata R; Vilatoba M; Muñoz L; Maraschio M; Fauda M; McCormack L; Gadano A; Boin IS; García JHP; Silva M
    Ann Hepatol; 2018 Mar; 17(2):256-267. PubMed ID: 29469048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods.
    Van Thiel DH; Yong S; Li SD; Kennedy M; Brems J
    Liver Transpl; 2004 May; 10(5):631-7. PubMed ID: 15108254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
    Nacif LS; Paranagua-Vezozzo DC; Matsuda A; Alves VAF; Carrilho FJ; Farias AQ; D'Albuquerque LC; Andraus W
    Arq Bras Cir Dig; 2018 Jun; 31(1):e1360. PubMed ID: 29947694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
    Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
    Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Liver Transplant Waiting List in Our Center.
    Emek E; Yesim Kara Z; Demircan FH; Serin A; Yazici P; Sahin T; Tokat Y; Bozkurt B
    Transplant Proc; 2019 Sep; 51(7):2413-2415. PubMed ID: 31474297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation.
    Senkerikova R; Frankova S; Sperl J; Oliverius M; Kieslichova E; Filipova H; Kautznerova D; Honsova E; Trunecka P; Spicak J
    Transplant Proc; 2014 Jun; 46(5):1426-9. PubMed ID: 24935308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization.
    Maddala YK; Stadheim L; Andrews JC; Burgart LJ; Rosen CB; Kremers WK; Gores G
    Liver Transpl; 2004 Mar; 10(3):449-55. PubMed ID: 15004776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
    Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
    Iacob S; Gheorghe L; Iacob R; Gheorghe C; Hrehoreţ D; Popescu I
    Chirurgia (Bucur); 2009; 104(3):267-73. PubMed ID: 19601457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
    Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
    J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
    Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
    J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Majno P; Berney T; Morel P; Mentha G; Combescure C
    Transpl Int; 2014 Jul; 27(7):686-95. PubMed ID: 24649861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.